1. Home
  2. GDC vs TNXP Comparison

GDC vs TNXP Comparison

Compare GDC & TNXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo GD Culture Group Limited

GDC

GD Culture Group Limited

N/A

Current Price

$3.81

Market Cap

241.3M

Sector

Industrials

ML Signal

N/A

Logo Tonix Pharmaceuticals Holding Corp.

TNXP

Tonix Pharmaceuticals Holding Corp.

N/A

Current Price

$13.61

Market Cap

220.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
GDC
TNXP
Founded
2015
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Steel/Iron Ore
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
241.3M
220.5M
IPO Year
N/A
2008

Fundamental Metrics

Financial Performance
Metric
GDC
TNXP
Price
$3.81
$13.61
Analyst Decision
Buy
Analyst Count
0
1
Target Price
N/A
$70.00
AVG Volume (30 Days)
37.1K
285.9K
Earning Date
01-01-0001
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$10,094,000.00
Revenue This Year
N/A
$7.00
Revenue Next Year
N/A
$708.37
P/E Ratio
$7.47
N/A
Revenue Growth
N/A
29.94
52 Week Low
$1.76
$12.35
52 Week High
$9.92
$69.65

Technical Indicators

Market Signals
Indicator
GDC
TNXP
Relative Strength Index (RSI) 51.10 36.55
Support Level $3.09 N/A
Resistance Level $4.41 $20.36
Average True Range (ATR) 0.42 0.68
MACD 0.07 -0.04
Stochastic Oscillator 64.52 25.41

Price Performance

Historical Comparison
GDC
TNXP

About GDC GD Culture Group Limited

GD Culture Group Ltd focuses its business on two segments mainly through the Company and two subsidiaries. 1) AI-driven digital human creation and customization; 2) Live streaming and e-commerce. The company has relentlessly been focusing on serving its customers and creating value for them through the continual innovation and optimization of its products and services. For the AI-driven digital human creation and customization sector, the Company uses AI algorithms and software to generate realistic 3D or 2D digital human models. AI algorithms and machine learning models are used to simulate human characteristics, such as facial expressions, body movements, and even speech patterns.

About TNXP Tonix Pharmaceuticals Holding Corp.

Tonix Pharmaceuticals Holding Corp is a biopharmaceutical company focused on developing, licensing and commercializing therapeutics to treat and prevent human disease and alleviate suffering. Tonix's development portfolio is focused on central nervous system (CNS) disorders. The company's immunology development portfolio consists of biologics to address organ transplant rejection, autoimmunity and cancer, including TNX-1500, which is a humanized monoclonal antibody targeting CD40-ligand (CD40L or CD154) being developed for the prevention of allograft rejection and for the treatment of autoimmune diseases. Tonix also has product candidates in development in the areas of rare disease and infectious disease.

Share on Social Networks: